• Home
  • Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.

Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.

Author List
McCluskey SM, Kamelian K, Musinguzi N, Kigozi S, Boum Y, Bwana MB, Muzoora C, Brumme ZL, Carrington M, Carlson J, Foley B, Hunt PW, Martin JN, Bangsberg DR, Harrigan PR, Siedner MJ, Haberer JE, Lee GQ
Publication
AIDS (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/175823536
Publication Year
2021
PubMed ID
33635845
Publication Title
McCluskey SM, Kamelian K, Musinguzi N, Kigozi S, Boum Y, Bwana MB, Muzoora C, Brumme ZL, Carrington M, Carlson J, Foley B, Hunt PW, Martin JN, Bangsberg DR, Harrigan PR, Siedner MJ, Haberer JE, Lee GQ. Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda. AIDS. 2021 06 01; 35(7):1083-1089.